| 名稱(chēng) | AI-Edigene® EGFR p.L861Q Reference Standard P |
| 型號(hào) | CBP10401 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | AI-Edigene® EGFR p.L861Q Reference Standard Plus |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 三陰性乳腺癌的一個(gè)突破口——BRCA基因檢測(cè)？
- 甲基丙二酸血癥（MMA）標(biāo)準(zhǔn)品上新
- STEAP1/2的細(xì)胞模型
- 一箭雙雕——IL-4R靶點(diǎn)和IL-4/IL-13雙重阻斷藥篩細(xì)胞模型
- ATCC細(xì)胞株所用培養(yǎng)基有何要求？
- 官宣！Ba/F3激酶穩(wěn)定細(xì)胞株&科佰激酶篩選平臺(tái)
- IL6藥物細(xì)胞篩選模型
- 心衰治療靶點(diǎn)：BNP/NPR1
- 從諾輝財(cái)報(bào)看甲基化市場(chǎng)，科佰生物助力甲基化標(biāo)準(zhǔn)品的開(kāi)發(fā)
- IL9細(xì)胞篩選模型
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10401AI-Edigene® EGFR p.L861Q Reference Standard P
- 詳細(xì)內(nèi)容
" _ue_custom_node_="true">
CBP10401 | |
| Format | Genomic DNA |
| Description | The L861Q mutation results in an amino acid substitution at position 861 in EGFR, from a leucine (L) to a glutamine (Q). This mutation occurs within exon 21, which encodes part of the kinase domain, and occurs with a frequency of approximately 2% in EGFR-mutated lung tumors (Mitsudomi and Yatabe 2010). This mutation is associated with increased sensitivity to the EGFR TKIs, erlotinib (Tarceva) and gefitinib (Iressa; Lynch et al. 2004). |
| Technical Data | |
| DNA Change | c.2582T>A |
| AA Change | p.L861Q |
| Mutation type | Substitution - Missense |
| Zygosity | Homozygous |
| Allelic Frequency | 100% |
| Transcript | ENST00000275493 |
| Cosmic ID | COSM6213 |
| Chr position(GRCh37) | chr7:55259524 |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)